UBS AM’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $183M | Sell |
|
|||||
|
2021
Q1 | $163M | Sell |
|
|||||
|
2020
Q4 | $199M | Sell |
|
|||||
|
2020
Q3 | $182M | Sell |
|
|||||
|
2020
Q2 | $186M | Sell |
|
|||||
|
2020
Q1 | $173M | Buy |
|
|||||
|
2019
Q4 | $205M | Buy |
|
|||||
|
2019
Q3 | $164M | Buy |
|
|||||
|
2019
Q2 | $205M | Buy |
|
|||||
|
2019
Q1 | $198M | Sell |
|
|||||
|
2018
Q4 | $161M | Sell |
|
|||||
|
2018
Q3 | $231M | Buy |
|
|||||
|
2018
Q2 | $206M | Sell |
|
|||||
|
2018
Q1 | $209M | Buy |
|
|||||
|
2017
Q4 | $224M | Buy |
|
|||||
|
2017
Q3 | $238M | Buy |
|
|||||
|
2017
Q2 | $145M | Buy |
|
|||||
|
2017
Q1 | $106M | Sell |
|
|||||
|
2016
Q4 | $108M | Buy |
|
|||||
|
2016
Q3 | $94.7M | Sell |
|
|||||
|
2016
Q2 | $102M | Buy |
|
|||||
|
2016
Q1 | $108M | Sell |
|
|||||
|
2015
Q4 | $153M | Sell |
|
|||||
|
2015
Q3 | $143M | Sell |
|
|||||
|
2015
Q2 | $200M | Buy |
|
|||||
|
2015
Q1 | $189M | Buy |
|
|||||
|
2014
Q4 | $184M | Sell |
|
|||||
|
2014
Q3 | $178M | Sell |
|
|||||
|
2014
Q2 | $173M | Sell |
|
|||||
|
2014
Q1 | $183M | Sell |
|
|||||
|
2013
Q4 | $189M | Sell |
|
|||||
|
2013
Q3 | $180M | Buy |
|
|||||
|
2013
Q2 | $90.3M | Buy |
|